Delivery Order SPE2DB20D3505-SPE2DB25FT7A1
Award Date
12/30/24
Potential Completion Date
12/31/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,325.38 firm fixed-price delivery order is for the supply of Letrozole 2.5 mg tablets, a medication used to treat breast cancer. The contract has an ultimate completion date of December 11, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,238.12 firm-fixed-price delivery order contract is for the supply of Letrozole 2.5 mg tablets, a medication used in the treatment of breast cancer. The contract has an ultimate completion date of October 30, 2024 and does not include any set-aside designations, indicating open competition.
AmerisourceBergen...
This federal contract award, valued at $8,169.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Letrozole 2.5 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,406.44, is for the delivery of Letrozole 2.5 mg tablets, a prescription medication.
The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award, valued at $2,153.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of letrozole 2.5 mg tablets, a pharmaceutical product, with a period of performance through October 29, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,045.56 firm fixed-price delivery order is for the supply of Letrozole 2.5 mg tablets, with an ultimate completion date of November 5, 2024. This contract is not designated as a set-aside.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of 4,566,403,935 tablets of the drug Letrozole 2.5 mg. The $14,750.91 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of November 13, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the supply of Letrozole 2.5 mg tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,519.85, was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. This delivery order contract has a firm fixed price and is set to expire on August 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,006.84, is for the delivery of 4566249338 - Letrozole 2.5 mg Tablets in 30-count packages. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 29, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime...
This federal contract award is for the delivery of Letrozole 2.5 mg tablet (90 count) to the Defense Logistics Agency (DLA), a major procurement agency within the U.S. Department of Defense (DoD). The contract, valued at $9,446.84, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation.
The contract does not have a set-aside designation and was awarded on a full and open competition basis, highlighting...